Liver Transplantation Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research, a leading market research firm, has recently released a comprehensive report on the global Liver Transplantation Market, providing valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. This report offers an in-depth overview of the liver transplantation landscape, presenting exclusive data and statistics that forecast the market's growth trajectory from 2023 to 2030.

The global liver transplantation market is forecast to expand at a CAGR of 7.1% and thereby increase from a value of US$ 1.5 Bn in 2023 to US$ 2.4 Bn by the end of 2030.

Key Insights

Liver Transplantation Market Size (2023E): US$1.5 Billion

Projected Market Value (2030F): US$2.4 Billion

Global Market Growth Rate (CAGR 2023 to 2030): 7.1%

Historical Market Growth Rate (CAGR 2018 to 2022): 6.4%

Liver Transplantation Market - Report Scope:

The Liver Transplantation Market encompasses a range of medical procedures, technologies, and pharmaceuticals related to liver transplantation. This market serves healthcare providers, pharmaceutical companies, and patients, offering solutions for liver failure and end-stage liver diseases. Market growth is driven by advancements in surgical techniques, organ preservation technologies, immunosuppressive drugs, and the increasing prevalence of liver disorders worldwide.

Market Growth Drivers:

The global Liver Transplantation Market benefits from several key growth drivers. Technological advancements in liver transplant procedures, including minimally invasive surgeries and living donor liver transplants, contribute to improved patient outcomes and reduced recovery times. The rising incidence of liver diseases, fueled by factors such as alcohol consumption, viral hepatitis, and non-alcoholic fatty liver disease (NAFLD), drives the demand for liver transplantation. Additionally, efforts to expand organ donation programs and increase public awareness enhance the availability of donor organs, supporting market growth.

Market Restraints:

Despite its positive outlook, the Liver Transplantation Market faces challenges such as organ shortage, high procedural costs, and the complexities of immune system management post-transplant. The limited availability of donor organs, ethical concerns surrounding organ procurement, and the need for lifelong immunosuppressive therapy pose challenges for both patients and healthcare providers. Addressing these barriers requires collaboration between medical professionals, regulatory authorities, and the public to promote organ donation, enhance procedural efficiency, and reduce associated costs.

Market Opportunities:

The Liver Transplantation Market presents significant opportunities for innovation and growth. Emerging trends such as xenotransplantation, 3D printing of liver tissues, and artificial liver support systems offer new avenues for research and development. Advances in personalized medicine, including genomics and precision immunosuppression, can enhance the success rates of liver transplants and reduce complications. Strategic partnerships between transplant centers, pharmaceutical companies, and research institutions enable collaborative efforts to address unmet needs and drive advancements in liver transplantation.

Key Questions Answered in the Report:

What is the Forecast CAGR of the Liver Transplantation Market?
What is the Market Size of the Market in the Year 2023?
Which Country Held the Largest Market Share in 2023?
What are the Key Players in the Liver Transplantation Market?
Which is the Fastest-Growing Segment in the End Use Segment?

Competitive Landscape and Business Strategies:

Leading players in the global Liver Transplantation Market, including [Insert Key Companies], focus on innovation, research and development, and strategic collaborations to maintain their market position and drive growth. These companies invest in the development of advanced surgical techniques, organ preservation methods, and immunosuppressive drugs. Collaborations with transplant centers, academic institutions, and regulatory authorities facilitate market access and promote best practices. Moreover, emphasis on patient education, community outreach, and advocacy initiatives fosters market growth and enhances patient outcomes in the rapidly evolving field of liver transplantation.

Key Companies Profiled:

Allosource
Conatus Pharmaceuticals Inc.
Digna Biotech S.L.
Dompe Farmaceutici S.p.A.
Isogenis, Inc.
RedHill Biopharma Ltd.
Thompson Surgical
Integra Life Sciences
Baxter International Inc.
XVIVO
VirTech Bio
Vital Therapies
HepaTx

Liver Transplantation Market Research Segmentation:

The Liver Transplantation Market is driven by the pivotal role of immunosuppressive drugs in post-transplant care, preventing organ rejection. Notably, calcineurin inhibitors, antimetabolites, and corticosteroids lead this category. Additionally, the Organ Preservation Solutions segment is rapidly advancing, ensuring the viability of donor organs during transportation.

Liver Transplantation Surgery takes center stage as the dominant treatment, offering a definitive solution for end-stage liver diseases. The highest market share is attributed to this category, emphasizing the rising need for real-time data monitoring during procedures. Simultaneously, the fastest-growing category is Post-Surgery Anti-Rejection Treatment, emphasizing the importance of preventing immune system attacks on transplanted livers.

Hospitals dominate as the primary end-use category, leveraging comprehensive care and robust infrastructure for liver transplantation. Adult Liver Transplantation Centers emerge as the fastest-growing segment, showcasing specialized expertise and a patient-centric approach to addressing the unique needs of adult patients.

Europe leads the global market, boasting integrated healthcare systems and collaborative efforts, establishing a robust transplantation ecosystem. Meanwhile, South Asia & Pacific emerge as the fastest-growing region, fueled by a rising disease burden and increased healthcare investments, creating an environment conducive to rapid liver transplantation growth.

By Product Type:

Organ Preservation Solutions
Immunosuppressive Drugs
Others

By Treatment Type:

Liver Transplantation Surgery
Post-Surgery Anti-Rejection Treatment
Cyclosporine
Tacrolimus
Sirolimus Prednisone Azathioprine
Mycophenolate Mofetil

By End-use:

Hospitals
Adult Liver Transplantation Centers
Ambulatory Surgical Centers

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33816

1. Executive Summary

1.1. Global Liver Transplantation Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Product Type Lifecycle Analysis
2.4. Liver Transplantation Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Liver Transplantation Market Outlook: Product Type
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
  - 3.3.3.1. Organ Preservation Solutions
  - 3.3.3.2. Immunosuppressive Drugs
  - 3.3.3.3. Others
3.4. Market Attractiveness Analysis: Product Type
3.5. Global Liver Transplantation Market Outlook: Treatment Type
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment Type, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
  - 3.5.3.1. Liver Transplantation Surgery
  - 3.5.3.2. Post-Surgery Anti-Rejection Treatment
  - 3.5.3.3. Cyclosporine
  - 3.5.3.4. Tacrolimus
  - 3.5.3.5. Sirolimus Prednisone Azathioprine
  - 3.5.3.6. Mycophenolate Mofetil
3.6. Market Attractiveness Analysis: Treatment Type
3.7. Global Liver Transplantation Market Outlook: End-use
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End-use, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
  - 3.7.3.1. Hospitals
  - 3.7.3.2. Adult liver transplantation centers
  - 3.7.3.3. Ambulatory surgical centers
3.8. Market Attractiveness Analysis: End-use

4. Global Liver Transplantation Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia & Pacific
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Product Type
- 5.3.3. By Treatment Type
- 5.3.4. By End-use
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 5.5.1. Organ Preservation Solutions
- 5.5.2. Immunosuppressive Drugs
- 5.5.3. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
- 5.6.1. Liver Transplantation Surgery
- 5.6.2. Post-Surgery Anti-Rejection Treatment
- 5.6.3. Cyclosporine
- 5.6.4. Tacrolimus
- 5.6.5. Sirolimus Prednisone Azathioprine
- 5.6.6. Mycophenolate Mofetil
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
- 5.7.1. Hospitals
- 5.7.2. Adult liver transplantation centers
- 5.7.3. Ambulatory surgical centers
5.8. Market Attractiveness Analysis

6. Europe Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Product Type
- 6.3.3. By Treatment Type
- 6.3.4. By End-use
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkey
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 6.5.1. Organ Preservation Solutions
- 6.5.2. Immunosuppressive Drugs
- 6.5.3. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
- 6.6.1. Liver Transplantation Surgery
- 6.6.2. Post-Surgery Anti-Rejection Treatment
- 6.6.3. Cyclosporine
- 6.6.4. Tacrolimus
- 6.6.5. Sirolimus Prednisone Azathioprine
- 6.6.6. Mycophenolate Mofetil
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
- 6.7.1. Hospitals
- 6.7.2. Adult liver transplantation centers
- 6.7.3. Ambulatory surgical centers
6.8. Market Attractiveness Analysis

7. East Asia Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Product Type
- 7.3.3. By Treatment Type
- 7.3.4. By End-use
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 7.5.1. Organ Preservation Solutions
- 7.5.2. Immunosuppressive Drugs
- 7.5.3. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
- 7.6.1. Liver Transplantation Surgery
- 7.6.2. Post-Surgery Anti-Rejection Treatment
- 7.6.3. Cyclosporine
- 7.6.4. Tacrolimus
- 7.6.5. Sirolimus Prednisone Azathioprine
- 7.6.6. Mycophenolate Mofetil
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
- 7.7.1. Hospitals
- 7.7.2. Adult liver transplantation centers
- 7.7.3. Ambulatory surgical centers
7.8. Market Attractiveness Analysis

8. South Asia & Oceania Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Product Type
- 8.3.3. By Treatment Type
- 8.3.4. By End-use
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 8.5.1. Organ Preservation Solutions
- 8.5.2. Immunosuppressive Drugs
- 8.5.3. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
- 8.6.1. Liver Transplantation Surgery
- 8.6.2. Post-Surgery Anti-Rejection Treatment
- 8.6.3. Cyclosporine
- 8.6.4. Tacrolimus
- 8.6.5. Sirolimus Prednisone Azathioprine
- 8.6.6. Mycophenolate Mofetil
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
- 8.7.1. Hospitals
- 8.7.2. Adult liver transplantation centers
- 8.7.3. Ambulatory surgical centers
8.8. Market Attractiveness Analysis

9. Latin America Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Product Type
- 9.3.3. By Treatment Type
- 9.3.4. By End-use
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 9.5.1. Organ Preservation Solutions
- 9.5.2. Immunosuppressive Drugs
- 9.5.3. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
- 9.6.1. Liver Transplantation Surgery
- 9.6.2. Post-Surgery Anti-Rejection Treatment
- 9.6.3. Cyclosporine
- 9.6.4. Tacrolimus
- 9.6.5. Sirolimus Prednisone Azathioprine
- 9.6.6. Mycophenolate Mofetil
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
- 9.7.1. Hospitals
- 9.7.2. Adult liver transplantation centers
- 9.7.3. Ambulatory surgical centers
9.8. Market Attractiveness Analysis

10. Middle East & Africa Liver Transplantation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Product Type
- 10.3.3. By Treatment Type
- 10.3.4. By End-use
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 10.5.1. Organ Preservation Solutions
- 10.5.2. Immunosuppressive Drugs
- 10.5.3. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
- 10.6.1. Liver Transplantation Surgery
- 10.6.2. Post-Surgery Anti-Rejection Treatment
- 10.6.3. Cyclosporine
- 10.6.4. Tacrolimus
- 10.6.5. Sirolimus Prednisone Azathioprine
- 10.6.6. Mycophenolate Mofetil
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2023 - 2030
- 10.7.1. Hospitals
- 10.7.2. Adult liver transplantation centers
- 10.7.3. Ambulatory surgical centers
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Immunosuppressive Drugs
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Allosource
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Conatus Pharmaceuticals Inc.
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Digna Biotech S.L.
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Dompe Farmaceutici S.p.A.
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. Isogenis, Inc.
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. RedHill Biopharma Ltd.
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Thompson Surgical
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Integra Life Sciences
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. Baxter International Inc.
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. XVIVO
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Product
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy
- 11.3.11. VirTech Bio
  - 11.3.11.1. Overview
  - 11.3.11.2. Segments and Product
  - 11.3.11.3. Key Financials
  - 11.3.11.4. Market Developments
  - 11.3.11.5. Market Strategy
- 11.3.12. Vital Therapies
  - 11.3.12.1. Overview
  - 11.3.12.2. Segments and Product
  - 11.3.12.3. Key Financials
  - 11.3.12.4. Market Developments
  - 11.3.12.5. Market Strategy
- 11.3.13. HepaTx
  - 11.3.13.1. Overview
  - 11.3.13.2. Segments and Product
  - 11.3.13.3. Key Financials
  - 11.3.13.4. Market Developments
  - 11.3.13.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations